Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-003 Lisboa, Portugal; Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 1829-516 Caparica, Portugal.
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-003 Lisboa, Portugal.
Colloids Surf B Biointerfaces. 2023 Oct;230:113486. doi: 10.1016/j.colsurfb.2023.113486. Epub 2023 Aug 1.
Infections associated with the surfaces of medical devices represent a critical problem due to biofilm formation and the growing resistance towards antibacterial drugs. This is particularly relevant in commonly used invasive devices such as silicone-based ones where a demand for alternative antibiofilm surfaces is increasing. In this work, an antimicrobial chitosan-biosurfactant hydrogel mesh was produced by 3D-printing. The 3D structure was designed to coat polydimethylsiloxane-based medical devices for infection prevention. Additionally, the porous 3D structure allows the incorporation of customized bioactive components. For this purpose, two biosurfactants (surfactin and sophorolipids) were biosynthesized and tested for their antimicrobial activity. In addition, the printing of surfactant-chitosan-based coatings was optimized, and the resulting 3D structures were characterized (i.e., wettability, FTIR-ATR, antimicrobial activity, and biocompatibility). Compared with surfactin, the results showed a better yield and higher antibacterial activity against Gram-positive bacteria for sophorolipids (SLs). Thus, SLs were used to produce chitosan-based 3D-printed coatings. Overall, the SLs-impregnated coatings showed the best antibacterial activity against Staphylococcus aureus planktonic bacteria (61 % of growth inhibition) and antibiofilm activity (2 log units reduction) when compared to control. Furthermore, concerning biocompatibility, the coatings were cytocompatible towards human dermal fibroblasts. Finally, the coating presented a mesh suitable to be filled with a model bioactive compound (i.e., hyaluronic acid), paving the way to be used for customized therapeutics.
由于生物膜的形成和抗菌药物耐药性的增加,与医疗器械表面相关的感染是一个严重的问题。这在常用的侵入性器械中尤为重要,如基于硅酮的器械,对替代抗生物膜表面的需求正在增加。在这项工作中,通过 3D 打印生产了一种抗菌壳聚糖-生物表面活性剂水凝胶网。3D 结构的设计目的是为了给基于聚二甲基硅氧烷的医疗器械涂层,以预防感染。此外,多孔的 3D 结构允许纳入定制的生物活性成分。为此,合成了两种生物表面活性剂(表面活性剂和槐糖脂),并测试了它们的抗菌活性。此外,还优化了基于表面活性剂的壳聚糖涂层的打印,并对所得的 3D 结构进行了表征(即润湿性、FTIR-ATR、抗菌活性和生物相容性)。与表面活性剂相比,结果表明槐糖脂具有更好的产率和更高的抗革兰氏阳性菌活性。因此,使用槐糖脂生产壳聚糖基 3D 打印涂层。总体而言,与对照相比,槐糖脂浸渍的涂层对浮游细菌金黄色葡萄球菌显示出最好的抗菌活性(抑制生长 61%)和抗生物膜活性(减少 2 个对数单位)。此外,关于生物相容性,该涂层对人皮肤成纤维细胞具有细胞相容性。最后,该涂层具有适合填充模型生物活性化合物(即透明质酸)的网格,为定制治疗铺平了道路。